Delhi | 25°C (windy) | Air: 185%

Charles River Laboratories launches Rep/Cap plasmid

  • Nishadil
  • January 16, 2024
  • 0 Comments
  • 0.25 minutes read
  • 18 Views
Charles River Laboratories launches Rep/Cap plasmid
Charles River Laboratories ( NYSE: CRL ) said it has launched its off the shelf Rep/Cap plasmid offering, designed to streamline adeno associated virus based gene therapy programs. “The reduction in production time and improved efficacy of the supply chain will help accomplish our ultimate goal of delivering safe, effective therapies to patients, faster," said Kerstin Dolph, Senior Vice President, Manufacturing. More on Charles River Laboratories Charles River Laboratories: Mr. Market Went From Overvaluation To Undervaluation Charles River: Q3 Points To Ongoing Deterioration